CardioMEMS
Device
Abbott Laboratories
Total Payments
$1.5M
Transactions
518
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $1.5M | 518 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.5M | 518 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CardioMEMS HF System Post Approval Study | Abbott Laboratories | $963,969 | 1 |
| INvesTigation to OptimizE Hemodynamic Management of HeartMate II Left VentricuLar Assist DEvice Patients using the CardioMEMS Pulmonary ArTery Pressure Sensor in Advanced Heart Failure (INTELLECT 2-HF) | Abbott Laboratories | $489,873 | 0 |
Top Doctors Receiving Payments for CardioMEMS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New Orleans, LA | $1.4M | 513 |
| , M.D | Cardiovascular Disease | Glendale, CA | $10,077 | 5 |
Ad
Manufacturing Companies
- Abbott Laboratories $1.5M
Product Information
- Type Device
- Total Payments $1.5M
- Total Doctors 1
- Transactions 518
About CardioMEMS
CardioMEMS is a device associated with $1.5M in payments to 1 healthcare providers, recorded across 518 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $1.5M was paid across 518 transactions to 1 doctors.
The most common payment nature for CardioMEMS is "Unspecified" ($1.5M, 100.0% of total).
CardioMEMS is associated with 2 research studies, including "CardioMEMS HF System Post Approval Study" ($963,969).